ACADIA Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
ACAD Key Statistics
Stock Snapshot
As of today, ACADIA Pharmaceuticals(ACAD) shares are valued at $28.42. The company's market cap stands at 5.16B, with a P/E ratio of 11.66.
On 2026-08-06, ACADIA Pharmaceuticals(ACAD) stock moved within a range of $28.32 to $29.48. With shares now at $28.42, the stock is trading +0.4% above its intraday low and -3.6% below the session's peak.
Trading volume for ACADIA Pharmaceuticals(ACAD) stock has reached 361.87K, versus its average volume of 1.76M.
The stock's 52-week range extends from a low of $19.69 to a high of $29.48.
The stock's 52-week range extends from a low of $19.69 to a high of $29.48.
ACAD News
...
BofA raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $31 from $30 and keeps a Buy rating on the shares. Following the Q2 report, the firm rai...
Ritu Baral, an analyst from TD Cowen, maintained the Buy rating on ACADIA Pharmaceuticals. The associated price target is $37.00. Unlock powerful investing too...
Analyst ratings
76%
of 21 ratingsMore ACAD News
ACADIA Pharmaceuticals stock has delivered a solid 38.5% gain over the past five years, yet recent short term returns have been softer. This puts more attention...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.